Richard H. Smith, President
Richard Smith, MS, CMPE, is a Principal in the nanotechnology commercialization firm, Nanoverse LLC. He is also the Co-Founder of the Nanotechnology Policy Foundation and the Nanotechnology Network. Prior to launching these organizations, he was a Senior Strategist for the Institute for Alternative Futures, a healthcare and pharma think tank in Washington, DC. Before joining IAF, Dick was the Director of the Global Forum on Technology Forecasting for Coates & Jarratt, Inc. He has been involved in the study of nanotechnology since 1994, writing his thesis on nanotechnology policy and serving on the biotechnology and nanotechnology study section and the final design team for the Department of Defense Military Health System 2025 task force. He co-chaired the symposium on the convergence of nanotechnology and biotechnology at the annual meeting of the AAAS in 2003. He is a frequent speaker on nanotechnology, especially its medical implications.
Dick was a strategic planner for AT&T, Unisys, and SONY and a Director of Planning and Research Administration for the Georgetown University Medical School. An active member of the Medical Group Management Association and the Academic Practice Assembly, he is a Certified Medical Practice Manager. He holds an MS in Science and Technology Studies from Virginia Tech and is completing a doctoral residency in Science and Technology Policy.
Clifford A. Martin, Vice President
Clifford A. Martin, PhD, has been President of Odyssey Consortium, a high technology systems analysis and design company, Vice-President of Engineering for the Silicon Valley Group, was a cofounder of Taunton Technology, Inc. (later known as VISX), and held several management positions with Perkin-Elmer Corporation. Dr. Martin's scientific expertise includes excimer lasers, high-resolution lithography, plasma assisted CVD for creation of X-ray masks, diamond-like films, new techniques for detection of dangerous gases, and plasma assisted polishing. He has been instrumental in guiding several medical device technologies through the FDA approval process.